Vijay Kumar Vasireddy
About Vijay Kumar Vasireddy
Data last updated:
Vijay Kumar Vasireddy is a Director at Difgen Pharmaceuticals Private Limited (since 2022), Additional Director at Prathyak Laboratories Private Limited (since 2025) and Additional Director at Vivint Pharma Private Limited (since 2025). The companies operate in Research & Development, Life Sciences and Chemicals and Materials. The 2 current companies with reported revenue have a combined latest revenue of ₹76.70 Cr; the largest is Difgen Pharmaceuticals Private Limited at ₹76.63 Cr (FY 2025). Earlier, Vijay Kumar Vasireddy was a Director at Celon Laboratories Private Limited (2010–2020) and Director at Mviyes Pharma Ventures Private Limited (2018–2020) and 1 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Difgen Pharmaceuticals Private Limited U72100TG2022PTC162383 | Director | 04 Nov 2022 | 2022 | ₹76.63 Cr (FY 2025) | Active |
| Prathyak Laboratories Private Limited U24290TG2022PTC166750 | Additional Director | 06 Aug 2025 | 2022 | ₹7.5 Lakh (FY 2025) | Active |
| Vivint Pharma Private Limited U24299TG2022PTC165671 | Additional Director | 06 Aug 2025 | 2022 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Celon Laboratories Private Limited U24232TG2001PTC036097 | Director | 29 Sep 2010 | 2001 | ₹148 Cr (FY 2025) | Active |
| Mviyes Pharma Ventures Private Limited U74999TG2017PTC116265 | Director | 28 Sep 2018 | 2017 | ₹20.4 Lakh (FY 2023) | Amalgamated |
 Eugia Pharma Specialities Limited U24297TG2013PLC087048 | Director | 16 Sep 2013 | 2013 | ₹4,829 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Vijay Kumar Vasireddy
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Vijay Kumar Vasireddy
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vijay Kumar Vasireddy
Vijay Kumar Vasireddy currently holds 3 directorships: Difgen Pharmaceuticals Private Limited (Director, since 04 Nov 2022, revenue ₹76.63 Cr (FY 2025)); Prathyak Laboratories Private Limited (Additional Director, since 06 Aug 2025, revenue ₹7.5 Lakh (FY 2025)); Vivint Pharma Private Limited (Additional Director, since 06 Aug 2025).
Vijay Kumar Vasireddy was first appointed on 29 Sep 2010 as Director at Celon Laboratories Private Limited. The most recent appointment on record is 06 Aug 2025 at Vivint Pharma Private Limited.
The 2 current companies of Vijay Kumar Vasireddy that report revenue have a combined latest revenue of ₹76.70 Cr: Difgen Pharmaceuticals Private Limited ₹76.63 Cr (FY 2025); Prathyak Laboratories Private Limited ₹7.5 Lakh (FY 2025).
Vijay Kumar Vasireddy held 3 earlier board appointments: Celon Laboratories Private Limited (Director, 29 Sep 2010 to 13 Nov 2020); Mviyes Pharma Ventures Private Limited (Director, 28 Sep 2018 to 23 Oct 2020); Eugia Pharma Specialities Limited (Director, 16 Sep 2013 to 23 Oct 2020).
The current boards of Vijay Kumar Vasireddy's companies include Amol Ashok Walke (Difgen Pharmaceuticals Private Limited), Krishna Chandrasekaran (Difgen Pharmaceuticals Private Limited), Narasimhan Sridhar Nagaarjun (Difgen Pharmaceuticals Private Limited), Punit Chunilal Thakrar (Difgen Pharmaceuticals Private Limited), Ramandeep Singh Jaj (Difgen Pharmaceuticals Private Limited), Santhanakrishnan Srinivasan (Difgen Pharmaceuticals Private Limited), among others.